Abstract
Purpose: To describe the course and outcome of treatment of advanced Acanthamoeba sclerokeratitis with intravenous pentamidine. Methods: A case of advanced Acanthamoeba sclerokeratitis was resistant to conventional therapy and was treated with intravenous pentamidine. The eye was later removed due to incapacitating pain. Results: The eye showed Acanthamoeba organisms within the cornea and evidence of acute and chronic inflammation throughout the remainder of the eye. The patient has survived without orbital recurrence for 2 years. Conclusions: This case demonstrates late inflammation with active Acanthameoba keratitis following systemic pentamidine therapy. © 2010 Kuennen et al.
Cite
CITATION STYLE
Kuennen, R. A., Smith, R. H., Mauger, T. F., & Craig, E. (2010). Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis. Clinical Ophthalmology, 4(1), 1145–1149. https://doi.org/10.2147/OPTH.S13831
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.